Latest News by Industry
• The experts voted 21-0 with one abstention in favor of the vaccine
The US Food and Drug Administration’s committee of independent vaccine experts on Tuesday voted to recommend authorization of Novavax Inc’s (NASDAQ: NVAX) Covid-19 vaccine for adults.
The experts voted 21-0 with one abstention in favor of the vaccine for people aged 18 years and above.
The next step for the pharma company would be to get an authorization from the FDA which usually follows recommendations of its experts.
Novavax Covid-19 vaccine would become the fourth vaccine option in the US if it gets approval from the FDA.
Novavax shot, which is a two-dose vaccine based on protein technology, is already available in over 40 countries.
Picture Credits: Reuters
ALSO READ: